Kinetic of the Maternally-Derived Anti-Parvovirus IgG During the Neonatal Period: A Quantitative Assessment

新生儿期母源性抗细小病毒IgG的动力学:定量评估

阅读:1

Abstract

BACKGROUND: Passive immunity (mainly IgG) protects canine neonates from the highly pathogenic and contagious canine parvovirus, while it can also largely interfere with parvovirus early vaccinations. OBJECTIVES: Quantitative evaluation of the anti-parvovirus IgG transferred to newborn puppies from immunised bitches during the neonatal period, as the influence of individual variations on the kinetics of the specific IgG was also estimated. METHODS: Sera samples from 80 new born puppies were taken at 10 day intervals in a dog kennel and quantitatively assessed for specific anti-parvovirus IgG with a commercial ELISA kit. The resultant data were subjected to specific statistical analysis. RESULTS: Statistical analysis definitely showed that the anti-parvovirus IgG sufficiently transferred from the vaccinated bitches to their offspring, so that the average titre calculated was 5675.5 and 2625.9 in the 10 and 20 day old puppies, respectively, which were both considered significantly higher than the protective threshold titre (810). In our setting, however, the average anti-parvovirus IgG titre of the one-month old puppies was not significantly estimated protective, 959.7 (median = 15.57) with a coefficient of variation of 148.6%. It was also estimated that factors including bitches' age, litters' diversity, puppies' age, the period from parvovirus vaccination to parturition and litter size reduced the passive anti-parvovirus IgG levels in the newborn puppies, while bitches' parity evaluated as a positive factor to boost passive anti-parvovirus IgG titre. CONCLUSIONS: These results raise our knowledge on the kinetics of passive anti-parvovirus IgG in newborn puppies and are useful for establishing parvovirus vaccination schedules.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。